Skip to main content
. 2003 Jun;89(6):621–624. doi: 10.1136/heart.89.6.621

Table 1.

Haemodynamic variables at rest and during dobutamine infusion

Carvedilol, 85 (7.6) mg/day Metoprolol CR/XL, 160 (16) mg/day
Variable At rest Dobutamine (5 μg/kg/min) Dobutamine (15 μg/kg/min) At rest Dobutamine (5 μg/kg/min) Dobutamine (15 μg/kg/min)
HR (beats/min) 57 (2.4) 57 (3.2) 56 (2.8) 57 (2.6) 60 (3.9) 76 (5.7)*†
SBP (mm Hg) 122 (6.4) 132 (8.1)* 168 (10.3)*† 123 (6.9) 128 (7.2) 130 (6.9)
DBP (mm Hg) 77 (2.1) 82 (2.2) 89 (2.6)*† 78 (3.1) 78 (2.1) 77 (2.6)
MAP (mm Hg) 92 (2.5) 100 (3.1)* 115 (4.0)*† 93 (3.7) 95 (3.4) 95 (3.8)
EF (%) 31 (3.4) 35 (3.6) 36 (3.6) 31 (2.2) 35 (2.6) 35 (2.7)
SV (ml) 58 (4.6) 72 (6.1)* 69 (6.2)* 61 (4.6) 66 (5.4) 68 (5.1)*
CO (l/min) 3.4 (0.3) 4.2 (0.4)* 3.9 (0.4)* 3.4 (0.4) 3.9 (0.5)(p=0.059) 5.1 (0.4)*†
TPR (RU) 29 (2.2) 26 (3.4) 31 (2.5) 29 (3.7) 27 (3.1) 19 (1.7)*†

Values are mean (SEM).

*p < 0.05 v rest; †p < 0.05 v values during infusion of 5 μg/kg/min dobutamine.

CO, cardiac output; DBP, diastolic blood pressure; EF, ejection fraction; HR, heart rate; MAP, mean arterial pressure; RU, resistance units; SBP, systolic blood pressure; SV, stroke volume; TPR, total peripheral resistance.